Mission
The Aveni Foundation supports the timely development of innovative targeted therapies for cancer and other diseases, thereby addressing a significant global health concern as cancer is a leading cause of death worldwide. The foundation is named in honor of Fr. Joseph Aveni, a priest who benefitted from a gene-targeted therapy.
Basic Information
Tax-Exempt
Founded in
2018
EIN
83-0731767
Total Assets
$381.9 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 1 of 1 goals
At a Glance
Impact of DeltaRex-G
Ruth Oliver, fifteen year pancreatic cancer survivor with DeltaRex-G.
Advancing Gene Therapy
Kendra Krause, fifteen year sarcoma 'NERD' (No Evidence of Recurring Disease) with DeltaRex-G.
Aveni Foundation Events
An inspired performance by Gustavo Santaolalla in support of Aveni Foundation.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
53
52
/100
Program Expense Ratio
87.10%
18
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.0007175
20
/20
Working Capital Ratio
0.8091
10
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2023
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 708.7K | 100.00% |
| Program Services | 0 | 0.00% |
| Investment Income | 4 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 708.7K | 100.00% |